NONA
RDY icon

Ninety One North America’s Dr. Reddy's Laboratories RDY Stock Holding History

Ninety One North America’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-278,135
Closed -$3.87M – 109
2020
Q3 		$3.87M Sell
278,135
-6,105
-2% -$72.8K 0.42% 58
2020
Q2 		$3.01M Buy
284,240
+163,740
+136% +$1.67M 0.31% 59
2020
Q1 		$972K Buy
+120,500
New +$1M 0.08% 91

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ninety One North America's RDY Position: Q4 2020 in Review

Ninety One North America sold out of Dr. Reddy's Laboratories (RDY) in Q4 2020, closing a stake of 278,135 shares — an estimated $3.87M sold.

Ninety One North America first reported a position in RDY in Q1 2020 and held it in 3 quarters. The position peaked at $3.87M in Q3 2020. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2020.

  • Ninety One North America reported no remaining Dr. Reddy's Laboratories position as of Q4 2020 after selling out during the quarter.
  • Ninety One North America sold 278,135 Dr. Reddy's Laboratories shares in Q4 2020, an estimated $3.87M.
  • Ninety One North America first reported a position in Dr. Reddy's Laboratories in Q1 2020 and held it in 3 quarters.
  • Ninety One North America's Dr. Reddy's Laboratories position peaked at $3.87M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2020.

Based on Ninety One North America's 13F filing for Q4 2020, filed 5 Feb 2021.